137 related articles for article (PubMed ID: 38499636)
41. High expression of DJ-1 promotes growth and invasion via the PTEN-AKT pathway and predicts a poor prognosis in colorectal cancer.
Lin Y; Chen Q; Liu QX; Zhou D; Lu X; Deng XF; Yang H; Zheng H; Qiu Y
Cancer Med; 2018 Mar; 7(3):809-819. PubMed ID: 29441725
[TBL] [Abstract][Full Text] [Related]
42. ERO1α promotes the proliferation and inhibits apoptosis of colorectal cancer cells by regulating the PI3K/AKT pathway.
Wu M; Li R; Qin J; Wang Z; Guo J; Lv F; Wang G; Huang Y
J Mol Histol; 2023 Dec; 54(6):621-631. PubMed ID: 37776473
[TBL] [Abstract][Full Text] [Related]
43. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
[TBL] [Abstract][Full Text] [Related]
44. TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway.
Sun Y; Ji B; Feng Y; Zhang Y; Ji D; Zhu C; Wang S; Zhang C; Zhang D; Sun Y
Oncol Rep; 2017 Jul; 38(1):43-52. PubMed ID: 28534983
[TBL] [Abstract][Full Text] [Related]
45. Aldolase A promotes cervical cancer cell radioresistance by regulating the glycolysis and DNA damage after irradiation.
Zhou J; Lei N; Qin B; Chen M; Gong S; Sun H; Qiu L; Wu F; Guo R; Ma Q; Li Y; Chang L
Cancer Biol Ther; 2023 Dec; 24(1):2287128. PubMed ID: 38010897
[TBL] [Abstract][Full Text] [Related]
46. INTS6 promotes colorectal cancer progression by activating of AKT and ERK signaling.
Ding X; Chen T; Shi Q; Nan P; Wang X; Xie D; Li J
Exp Cell Res; 2021 Oct; 407(2):112826. PubMed ID: 34508742
[TBL] [Abstract][Full Text] [Related]
47. Fructose-bisphosphate aldolase a is a potential metastasis-associated marker of lung squamous cell carcinoma and promotes lung cell tumorigenesis and migration.
Du S; Guan Z; Hao L; Song Y; Wang L; Gong L; Liu L; Qi X; Hou Z; Shao S
PLoS One; 2014; 9(1):e85804. PubMed ID: 24465716
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
[TBL] [Abstract][Full Text] [Related]
49. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
50. Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway.
Hou B; Li W; Li J; Ma J; Xia P; Liu Z; Zeng Q; Zhang X; Chang D
Oncol Rep; 2020 Feb; 43(2):536-548. PubMed ID: 31894339
[TBL] [Abstract][Full Text] [Related]
51. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway.
Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X
Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539
[TBL] [Abstract][Full Text] [Related]
52. miR-132 inhibits colorectal cancer invasion and metastasis via directly targeting ZEB2.
Zheng YB; Luo HP; Shi Q; Hao ZN; Ding Y; Wang QS; Li SB; Xiao GC; Tong SL
World J Gastroenterol; 2014 Jun; 20(21):6515-22. PubMed ID: 24914372
[TBL] [Abstract][Full Text] [Related]
53. [Expression and significance of Bmi-1 and Ki67 in colorectal carcinoma tissues].
Lin MX; Wen ZF; Feng ZY; He D
Ai Zheng; 2008 Dec; 27(12):1321-6. PubMed ID: 19080002
[TBL] [Abstract][Full Text] [Related]
54. MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/CDH1 and blocking PI3K/AKT signaling.
Chen X; Wang W; Li Y; Huo Y; Zhang H; Feng F; Xi W; Zhang T; Gao J; Yang F; Chen S; Yang A; Wang T
J Exp Clin Cancer Res; 2021 Oct; 40(1):341. PubMed ID: 34706761
[TBL] [Abstract][Full Text] [Related]
55. Expression of HAX-1 in human colorectal cancer and its clinical significance.
Wei XJ; Li SY; Yu B; Chen G; Du JF; Cai HY
Tumour Biol; 2014 Feb; 35(2):1411-5. PubMed ID: 24057929
[TBL] [Abstract][Full Text] [Related]
56. Overexpression of gene DEP domain containing 1 and its clinical prognostic significance in colorectal cancer.
Shen X; Han J
J Clin Lab Anal; 2020 Dec; 34(12):e23634. PubMed ID: 33140894
[TBL] [Abstract][Full Text] [Related]
57. Loss-of-Function Genetic Screening Identifies Aldolase A as an Essential Driver for Liver Cancer Cell Growth Under Hypoxia.
Niu Y; Lin Z; Wan A; Sun L; Yan S; Liang H; Zhan S; Chen D; Bu X; Liu P; Chen C; He W; Lu X; Wan G
Hepatology; 2021 Sep; 74(3):1461-1479. PubMed ID: 33813748
[TBL] [Abstract][Full Text] [Related]
58. Identification of aldolase A as a potential diagnostic biomarker for colorectal cancer based on proteomic analysis using formalin-fixed paraffin-embedded tissue.
Yamamoto T; Kudo M; Peng WX; Takata H; Takakura H; Teduka K; Fujii T; Mitamura K; Taga A; Uchida E; Naito Z
Tumour Biol; 2016 Oct; 37(10):13595-13606. PubMed ID: 27468721
[TBL] [Abstract][Full Text] [Related]
59. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
60. Expression of TUSC3 and its prognostic significance in colorectal cancer.
Zhu YF; Dong M
Pathol Res Pract; 2018 Sep; 214(9):1497-1503. PubMed ID: 30115537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
